Source: Getty Images Marginal zone lymphoma is a slow-growing B-cell lymphoma with multiple subtypes and a heterogeneous presentation. Treatment options include radiation therapy, antibiotic/antiviral ...

Dr Burtness shares some of her highlights from the AACR Annual Meeting 2026, including results from studies on head and neck squamous cell carcinoma, advanced solid tumors, nasopharyngeal cancer, and ...

TP53 mutation status may inform early consolidation or alternative strategies to CAR T-cell therapy. n this single-center retrospective analysis of 69 patients treated with tisagenlecleucel, TP53 ...

Rectal cancer is occurring earlier and killing younger adults faster, according to a study presented at Digestive Disease Week 2026, held from May 2 to 5 in Chicago. Mythili Menon Pathiyil, MD, from ...

Marked racial and socioeconomic disparities significantly influence survival outcomes in patients with PCNSL across the US population.

Improvements in some domains of cognitive function seen for patients with cancer receiving chemotherapy reporting cognitive problems.

Investigators evaluated ctDNA as a prognostic marker for patients with follicular lymphoma in the phase III GALLIUM trial.

ACOG recommends clinician-collected hrHPV screening every 5 years as the primary screening method for patients aged 30-65 years. The American College of Obstetricians and Gynecologists (ACOG) now ...

(HealthDay News) — A competing risk model provides well-calibrated absolute risk estimates for a first metachronous cutaneous squamous cell carcinoma (cSCC) after an index tumor, according to a study ...

(HealthDay News) — The U.S. Food and Drug Administration (FDA) is moving to speed drug development and review by launching real-time clinical trials. The move could soon mean more options for patients ...